Gold nanoparticles: A critical review of therapeutic applications and toxicological aspects

Journal of Toxicology and Environmental Health - Part B: Critical Reviews

Volumn 19, Issue 3-4, 2016, Pages 129-148

  Hornos Carneiro, Maria Fernanda ^a   Barbosa, Fernando ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIRHEUMATIC AGENT; GOLD NANOPARTICLE; ANTIINFLAMMATORY AGENT; GOLD; METAL NANOPARTICLE;

ADVERSE DRUG REACTION; ANGIOGENESIS; ANOREXIA; ANTIANGIOGENIC ACTIVITY; ANTIANGIOGENIC THERAPY; ANTIINFLAMMATORY ACTIVITY; APLASTIC ANEMIA; ARTICLE; DRUG SAFETY; EXPERIMENTAL DESIGN; HUMAN; LIVER INJURY; NANOMEDICINE; NEPHROTOXICITY; NONHUMAN; PHYSICAL CHEMISTRY; PROTEINURIA; RHEUMATOID ARTHRITIS; WEIGHT REDUCTION; ANIMAL; ANIMAL MODEL; MOUSE; RAT;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTI-INFLAMMATORY AGENTS; GOLD; HUMANS; METAL NANOPARTICLES; MICE; MODELS, ANIMAL; RATS;

EID: 84976444272     PISSN: 10937404     EISSN: 15216950     Source Type: Journal    
DOI: 10.1080/10937404.2016.1168762     Document Type: Article

References (123)

1. W.H.Abou-Khalil,, A.A.Yunis, and S.Abou-Khalil. 1981. Discriminatory effects of gold compounds and carriers on mitochondria isolated from different tissues. Biochemical Pharmacology 30:3181–86. doi:10.1016/0006-2952(81)90516-5.
2. A.O.Afuwape,, S.Kiriakidis, and E.M.Paleolog. 2002. The role of the angiogenic molecule VEGF in the pathogenesis of rheumatoid arthritis. Journal of Histology & Histopathology 17:961–72.
3. S.Alex,, and A.Tiwari. 2015. Functionalized gold nanoparticles: Synthesis, properties and applications—A review. Journal of Nanoscience and Nanotechnology 15:1869–94. doi:10.1166/jnn.2015.9718.
4. A.M.Alkilany,, and C.J.Murphy. 2010. Toxicity and cellular uptake of gold nanoparticles: What we have learned so far? Journal of Nanoparticle Research 12:2313–33. doi:10.1007/s11051-010-9911-8.
5. R.R.Arvizo,, S.Rana, O.R.Miranda, R.Bhattacharya, V.M.Rotello, and P.Mukherjee. 2011. Mechanism of anti-angiogenic property of gold nanoparticles: Role of nanoparticle size and surface charge. Nanomedicine 7:580–87.
6. S.M.Attar, 2010. Adverse effects of low dose methotrexate in rheumatoid arthritis patients. A hospital-based study. Saudi Medical Journal 31:909–15.
7. U.auf dem Keller,, A.Kumin, S.Braun, and S.Werner. 2006. Reactive oxygen species and their detoxification in healing skin wounds. Journal of Investigative Dermatology Symposium Proceedings 11:106–11. doi:10.1038/sj.jidsymp.5650001.
8. A.E.Aust,, P.M.Cook, and R.F.Dodson. 2011. Morphological and chemical mechanisms of elongated mineral particle toxicities. Journal of Toxicology and Environmental Health, Part B 14:40–75. doi:10.1080/10937404.2011.556046.
9. M.Bednarski,, M.Dudek, J.Knutelska, L.Nowiński, J.Sapa, M.Zygmunt, G.Nowak, M.Luty-Błocho, M.Wojnicki, K.Fitzner, and M.Tęsiorowski. 2015. The influence of the route of administration of gold nanoparticles on their tissue distribution and basic biochemical parameters: In vivo studies. Pharmacological Reports 67:405–9. doi:10.1016/j.pharep.2014.10.019.
10. O.Bondarenko,, K.Juganson, A.Ivask, K.Kasemets, M.Mortimer, and A.Kahru. 2013. Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: A critical review. Archives of Toxicology 87:1181–200. doi:10.1007/s00204-013-1079-4.
11. P.Borm,, F.C.Klaessig, T.D.Landry, B.Moudgil, J.Pauluhn, K.Thomas, R.Trottier, and S.Wood. 2006. Research strategies for safety evaluation of nanomaterials, part V: Role of dissolution in biological fate and effects of nanoscale particles. Toxicological Sciences 90:23–32. doi:10.1093/toxsci/kfj084.
12. D.M.Brown,, H.Johnston, E.Gubbins, and V.J.Stone. 2014. Cytotoxicity and cytokine release in rat hepatocytes, C3A cells and macrophages exposed to gold nanoparticles–effect of biological dispersion media or corona. Journal of Biomedical Nanotechnology 10:3416–29. doi:10.1166/jbn.2014.1871.
13. D.Cabuzu,, A.Cirja, and R.Puiu. 2015. Grumezescu AM1. Biomedical applications of gold nanoparticles. Current Topics in Medicinal Chemistry 15:1605–13. doi:10.2174/1568026615666150414144750.
14. R.L.Cecil, 1940. Gold therapy in rheumatoid arthritis. Transactions of the American Clinical and Climatological Association 56:187–98.
15. G.D.Champion,, G.G.Graham, and J.B.Ziegler. 1990. The gold complexes. Baillière’s Clinical Rheumatology 4:491–534. doi:10.1016/S0950-3579(05)80005-6.
16. H.Chen,, Z.Wang, X.Ma, S.Zong, and Y.Cui. 2013. Magnetically controllable dual-mode nanoprobes for cell imaging with an onion-liked structure. Talanta 116:978–84. doi:10.1016/j.talanta.2013.08.015.
17. X.Chen,, J.Zhang, Y.Huang, Z.Tong, and M.Huang. 2009a. Catalytic reduction of nitric oxide with carbon monoxide on copper-cobalt oxides supported on nano-titanium dioxide. Journal of Environmental Sciences 21:1296–301. doi:10.1016/S1001-0742(08)62418-3.
18. Y.S.Chen,, Y.C.Hung, I.Liau, and G.S.Huang. 2009b. Assessment of the in vivo toxicity of gold nanoparticles. Nanoscale Research Letters 4:858–64. doi:10.1007/s11671-009-9334-6.
19. E.E.Connor,, J.Mwamuka, A.Gole, C.J.Murphy, and M.D.Wyatt. 2005. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325–27. doi:10.1002/(ISSN)1613-6829.
20. R.Coradeghini,, S.Gioria, C.P.Garcia, P.Nativo, F.Franchini, D.Gilliland, J.Ponti, and F.Rossi. 2013. Size-dependent toxicity and cell interaction mechanisms of gold nanoparticles on mouse fibroblasts. Toxicology Letters 217:205–16. doi:10.1016/j.toxlet.2012.11.022.
21. Y.Cui,, H.Chen, L.Hou, B.Zhang, B.Liu, G.Chen, and D.Tang. 2012. Nanogold-polyaniline-nanogold microspheres-functionalized molecular tags for sensitive electrochemical immunoassay of thyroid-stimulating hormone. Analytica Chimica Acta 738:76–84. doi:10.1016/j.aca.2012.06.013.
22. P.Davis,, C.Johnston, C.L.Miller, and K.Wong. 1983. Effects of gold compounds on the function of phagocytic cells. II. Inhibition of superoxide radical generation by tripeptide-activated polymorphonuclear leukocytes. Arthritis and Rheumatism 26:82–86. doi:10.1002/(ISSN)1529-0131.
23. P.Davis,, H.Menard, J.Thompson, M.Harth, and F.Beaudet. 1985. One-year comparative study of gold sodium thiomalate and auranofin in the treatment of rheumatoid arthritis. Journal of Rheumatology 12:60–67.
24. W.H.De Jong,, W.I.Hagens, P.Krystek, M.C.Burger, A.J.A.M.Sips, and R.E.Geertsma. 2008. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29:1912–19. doi:10.1016/j.biomaterials.2007.12.037.
25. Z.J.Deng,, M.Liang, M.Monteiro, I.Toth, and R.F.Minchin. 2011. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation. Nature Nanotechnology 6:39–44. doi:10.1038/nnano.2010.250.
26. C.Di Guglielmo,, J.De Lapuente, C.Porredon, D.Ramos-Lopez, J.Sendra, and M.Borras. 2012. In vitro safety toxicology data for evaluation of gold nanoparticles—Chronic cytotoxicity, genotoxicity and uptake. Journal of Nanoscience and Nanotechnology 12:6185–91. doi:10.1166/jnn.2012.6430.
27. M.J.Dimartino,, and D.T.Walz. 1977. Inhibition of lysosomal enzyme release from rat leukocytes by auranofin. A new chrysotherapeutic agent. Inflammation 2:131–42. doi:10.1007/BF00918675.
28. M.A.Dkhil,, A.A.Bauomy, M.S.Diab, and S.Al-Quraishy. 2015. Antioxidant and hepatoprotective role of gold nanoparticles against murine hepatic schistosomiasis. International Journal of Nanomedicine 10:7467–75.
29. J.F.Dorsey,, L.Sun, D.Y.Joh, A.Witztum, G.D.Kao, M.Alonso-Basanta, S.Avery, S.M.Hahn, A.Al Zaki, and A.Tsourkas. 2013. Gold nanoparticles in radiation research: Potential applications for imaging and radiosensitization. Translational Cancer Research 2:280–91.
30. E.C.Dreaden,, M.A.Mackey, X.Huang, B.Kang, and M.A.El-Sayed. 2011. Beating cancer in multiple ways using nanogold. Chemical Society Reviews 40:3391–404. doi:10.1039/c0cs00180e.
31. L.Dykman,, and N.Khlebtsov. 2012. Gold nanoparticles in biomedical applications: Recent advances and perspectives. Chemical Society Reviews 41:2256–82. doi:10.1039/C1CS15166E.
32. J.A.Edgar,, and M.B.Cortie. 2009. Nanotechnological applications of gold. In Gold science and applications, ed. C.Corti and R.Holliday, 369–97. London, UK: Taylor & Francis.
33. G.Eisenbrand,, B.Pool-Zobel, V.Baker, M.Balls, B.J.Blaauboer, A.Boobis, A.Carere, S.Kevekordes, J.C.Lhuguenot, R.Pieters, and J.Kleiner. 2002. Methods of in vitro toxicology. Food and Chemical Toxicology 40:193–236. doi:10.1016/S0278-6915(01)00118-1.
34. P.M.Favi,, M.Gao, L.Johana Sepulveda Arango, S.P.Ospina, M.Morales, J.J.Pavon, and T.J.Webster. 2015. Shape and surface effects on the cytotoxicity of nanoparticles: Gold nanospheres versus gold nanostars. Journal of Biomedical Materials Research Part A 103:3449–62. doi:10.1002/jbm.v103.11.
35. A.Federico,, F.Morgillo, C.Tuccillo, F.Ciardiello, and C.Loguercio. 2007. Chronic inflammation and oxidative stress in human carcinogenesis. International Journal of Cancer 121:2381–86. doi:10.1002/(ISSN)1097-0215.
36. D.T.Felson,, J.J.Anderson, and R.F.Meenan. 1990. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Resultsoftwometaanalyses. Arthritis and Rheumatism 33:1449–61. doi:10.1002/(ISSN)1529-0131.
37. G.K.Ferreira,, E.Cardoso, F.S.Vuolo, M.Michels, E.T.Zanoni, M.Carvalho-Silva, L.M.Gomes, F.Dal-Pizzol, G.T.Rezin, E.L.Streck, and M.M.Paula. 2015. Gold nanoparticles alter parameters of oxidative stress and energy metabolism in organs of adult rats. Biochemistry and Cell Biology 93:548–57. doi:10.1139/bcb-2015-0030.
38. S.Fraga,, A.Brandao, M.E.Soares, T.Morais, J.A.Duarte, L.Pereira, L.Soares, C.Neves, E.Pereira, L.Bastos Mde, and H.Carmo. 2014. Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration. Nanomedicine 10:1757–66.
39. M.Fumagalli,, C.Incorvaia, F.Nitti, M.Broggini, E.Baratelli, P.Balzarini, L.Galvani, and G.G.Romagnoni. 2002. The assessment of quality of life as a measure of gold salts treatment efficacy in rheumatoid arthritis. Minerva Medica 93:199–202.
40. M.Ghobadian,, M.Nabiuni, K.Parivar, M.Fathi, and J.Pazooki. 2012. Toxic effects of magnesium oxide nanoparticles on early developmental and larval stages of zebrafish (Danio rerio). Ecotoxicology and Environmental Safety 122 (EES):15454.
41. S.T.Gilani,, D.A.Khan, F.A.Khan, and M.Ahmed. 2012. Adverse effects of low dose methotrexate in rheumatoid arthritis patients. Journal of the College of Physicians and Surgeona Pakistan 22:101–04.
42. D.A.Giljohann,, D.S.Seferos, W.L.Daniel, M.D.Massich, P.C.Patel, and C.A.Mirkin. 2010. Gold nanoparticles for biology and medicine. Angewandte Chemie International Edition 49:3280–94. doi:10.1002/anie.200904359.
43. R.L.Goldberg,, D.P.Parrott, S.R.Kaplan, and G.C.Fuller. 1980. Effect of gold sodium thiomalate on proliferation of human rheumatoid synovial cells and on collagen synthesis in tissue culture. Biochemical Pharmacology 29:869–76. doi:10.1016/0006-2952(80)90216-6.
44. C.M.Goodman,, C.D.McCusker, T.Yilmaz, and V.M.Rotello. 2004. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjugate Chemistry 15:897–900. doi:10.1021/bc049951i.
45. M.Gulumian,, and V.Vallyathan. 2010. Nanoparticles and potential human health implications: Past and future directions. Preface. Journal of Toxicology and Environmental Health, Part A 73:339–40. doi:10.1080/15287390903584339.
46. N.Hadrup,, and H.R.Lam. 2014. Oral toxicity of silver ions, silver nanoparticles and colloidal silver–A review. Regulatory Toxicology and Pharmacology 68:1–7. doi:10.1016/j.yrtph.2013.11.002.
47. N.Hadrup,, A.K.Sharma, M.Poulsen, and E.Nielsen. 2015. Toxicological risk assessment of elemental gold following oral exposure to sheets and nanoparticles - A review. Regulatory Toxicology and Pharmacology 72:216–21. doi:10.1016/j.yrtph.2015.04.017.
48. B.Halliwell,, and S.Chirico. 1993. Lipid peroxidation: Its mechanism, measurement, and significance. American Journal of Clinical Nutrition 57:715S–724S; discussion 724S-725S.
49. N.B.Hartmann,, K.A.Jensen, A.Baun, K.Rasmussen, H.Rauscher, R.Tantra, D.Cupi, D.Gilliland, F.Pianella, and J.M.R.Sintes. 2015. Techniques and protocols for dispersing nanoparticle powders in aqueous media—Is there a rationale for harmonization? Journal of Toxicology and Environmental Health, Part B 18:299–326. doi:10.1080/10937404.2015.1074969.
50. T.S.Hauck,, A.A.Ghazani, and W.C.Chan. 2008. Assessing the effect of surface chemistry on gold nanorod uptake, toxicity, and gene expression in mammalian cells. Small 4:153–59. doi:10.1002/(ISSN)1613-6829.
51. G.J.Higby, 1982. Gold in medicine: A review of its use in the West before 1900. Gold Bulletin 15:130–40. doi:10.1007/BF03214618.
52. R.J.Horton, 1983. Comparative safety and efficacy of auranofin and parenteral gold compounds: A review. Scandinavian Journal of Rheumatology 12:100–10. doi:10.3109/03009748309095361.
53. K.Huang,, H.Ma, J.Liu, S.Huo, A.Kumar, T.Wei, X.Zhang, S.Jin, Y.Gan, P.C.Wang, S.He, and X.J.Liang. 2012a. Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo. ACS Nano 6:4483–93. doi:10.1021/nn301282m.
54. X.Huang,, P.K.Jain, I.H.El-Sayed, and M.A.El-Sayed. 2007. Gold nanoparticles: Interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine 2:681–93. doi:10.2217/17435889.2.5.681.
55. Y.J.Huang,, A.L.Shiau, S.Y.Chen, Y.L.Chen, C.R.Wang, C.Y.Tsai, M.Y.Chang, Y.T.Li, C.H.Leu, and C.L.Wu. 2012b. Multivalent structure of galectin-1-nanogold complex serves as potential therapeutics for rheumatoid arthritis by enhancing receptor clustering. European Cells & Materials 23:170–81; discussion 181.
56. E.Hutter,, S.Boridy, S.Labrecque, M.Lalancette-Hebert, J.Kriz, F.M.Winnik, and D.Maysinger. 2010. Microglial response to gold nanoparticles. ACS Nano 4:2595–606. doi:10.1021/nn901869f.
57. J.Jeong,, J.Kim, S.H.Seok, and W.S.Cho. 2015. Indium oxide (InO) nanoparticles induce progressive lung injury distinct from lung injuries by copper oxide (CuO) and nickel oxide (NiO) nanoparticles. Archives of Toxicology 90:817–28. doi:10.1007/s00204-015-1493-x.
58. M.A.Kamrin, 2007. The “low dose” hypothesis: Validity and implications for human risk. International Journal of Toxicology 26:13–23. doi:10.1080/10915810601117968.
59. A.Kanayama,, and Y.Miyamoto. 2007. Apoptosis triggered by phagocytosis-related oxidative stress through FLIPS down-regulation and JNK activation. Journal of Leukocyte Biology 82:1344–52. doi:10.1189/jlb.0407259.
60. W.F.Kean,, and I.R.Kean. 2008. Clinical pharmacology of gold. Inflammopharmacology 16:112–25. doi:10.1007/s10787-007-0021-x.
61. S.Kelly,, M.Bombardieri, F.Humby, N.Ng, A.Marrelli, S.Riahi, M.DiCicco, A.Mahto, L.Zou, D.Pyne, R.E.Hands, and C.Pitzalis. 2015. Angiogenic gene expression and vascular density are reflected in ultrasonographic features of synovitis in early rheumatoid arthritis: An observational study. Arthritis Research & Therapy 13:17–58.
62. M.M.Kemp,, A.Kumar, S.Mousa, E.Dyskin, M.Yalcin, P.Ajayan, R.J.Linhardt, and S.A.Mousa. 2009. Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties. Nanotechnology 20:455104. doi:10.1088/0957-4484/20/45/455104.
63. A.Kermanizadeh,, I.Gosesn, L.MacCalman, H.Johnston, P.H.Danielsen, N.R.Jacobsen, A.-G.Lenz, T.Fernandes, R.P.F.Schins, F.R.Cassee, H.Wallin, W.Kreyling, T.Stoeger, S.Loft, P.Moller, L.Tran, and V.Stone. 2016. A multi-laboratory toxicological assessment of a panel of ten engineered nanomaterials to human health-ENPRA Project—The highlights, limitations and current and future challenges. Journal Toxicogical Environment Health, Part B 19: 1–28.
64. 2 composites. Journal of Photochemistry and Photobiology B: Biology 149:196–203. doi:10.1016/j.jphotobiol.2015.05.011.
65. K.T.Kim,, T.Zaikova, J.E.Hutchison, and R.L.Tanguay. 2013a. Gold nanoparticles disrupt zebrafish eye development and pigmentation. Toxicological Sciences 133:275–88. doi:10.1093/toxsci/kft081.
66. Y.-W.Kim,, X.Z.West, and T.V.Byzova. 2013b. Inflammation and oxidative stress in angiogenesis and vascular disease. Journal of Molecular Medicine 91:323–28. doi:10.1007/s00109-013-1007-3.
67. W.K.Ko,, D.N.Heo, H.J.Moon, S.J.Lee, M.S.Bae, J.B.Lee, I.C.Sun, H.B.Jeon, H.K.Park, and I.K.Kwon. 2015. The effect of gold nanoparticle size on osteogenic differentiation of adipose-derived stem cells. Journal of Colloid and Interface Science 438:68–76. doi:10.1016/j.jcis.2014.08.058.
68. S.Konisti,, S.Kiriakidis, and E.M.Paleolog. 2012. Hypoxia–a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nature Reviews Rheumatology 8:153–62. doi:10.1038/nrrheum.2011.205.
69. J.K.Kundu,, and Y.J.Surh. 2012. Emerging avenues linking inflammation and cancer. Free Radical Biology and Medicine 52:2013–37. doi:10.1016/j.freeradbiomed.2012.02.035.
70. S.Lal,, S.E.Clare, and N.J.Halas. 2008. Nanoshell-enabled photothermal cancer therapy: Impending clinical impact. ACC Chem Res 41:1842–51. doi:10.1021/ar800150g.
71. C.Lasagna-Reeves,, D.Gonzalez-Romero, M.A.Barria, I.Olmedo, A.Clos, V.M.SadagopaRamanujam, A.Urayama, L.Vergara, M.J.Kogan, and C.Soto. 2010. Bioaccumulation and toxicity of gold nanoparticles after repeated administration in mice. Biochemical and Biophysical Research Communications 393:649–55. doi:10.1016/j.bbrc.2010.02.046.
72. U.Lee,, C.J.Yoo, Y.J.Kim, and Y.M.Yoo. 2016. Cytotoxicity of gold nanoparticles in human neural precursor cells and rat cerebral cortex. Journal of Bioscience and Bioengineering 121:341–44. doi:10.1016/j.jbiosc.2015.07.004.
73. A.J.Lehman,, J.M.Esdaile, A.V.Klinkhoff, E.Grant, A.Fitzgerald, J.Canvin, and M.S.Grp. 2005. A 48-week, randomized, double-blind, double-observer, placebo- controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis - Results of The METGO Study. Arthritis and Rheumatism 52:1360–70. doi:10.1002/art.21018.
74. L.Leonavičienė,, G.Kirdaitė, R.Bradūnaitė, D.Vaitkienė, A.Vasiliauskas, D.Zabulytė, A.Ramanavičienė, A.Ramanavičius, T.Ašmenavičius, and Z.Mackiewicz. 2012. Effect of gold nanoparticles in the treatment of established collagen arthritis in rats. Medicina (Kaunas) 48:91–101.
75. J.Lunec,, D.R.Blake, S.J.McCleary, S.Brailsford, and P.A.Bacon. 1985. Self-perpetuating mechanisms of immunoglobulin G aggregation in rheumatoid inflammation. Journal of Clinical Investigation 76:2084–90. doi:10.1172/JCI112212.
76. C.McCracken,, A.Zane, D.A.Knight, E.Hommel, P.K.Dutta, and W.J.Waldman. 2015. Oxidative stress-mediated inhibition of intestinal epithelial cell proliferation by silver nanoparticles. Toxicology In Vitro 29:1793–808. doi:10.1016/j.tiv.2015.07.017.
77. Y.Miyachi,, A.Yoshioka, S.Imamura, and Y.Niwa. 1987. Anti-oxidant effects of gold compounds. British Journal of Dermatology 116:39–46. doi:10.1111/bjd.1987.116.issue-1.
78. T.Morais,, M.E.Soares, J.A.Duarte, L.Soares, S.Maia, P.Gomes, E.Pereira, S.Fraga, H.Carmo, and L.Bastos Mde. 2012. Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat. European Journal of Pharmaceutics and Biopharmaceutics 80:185–93. doi:10.1016/j.ejpb.2011.09.005.
79. P.Mukherjee,, R.Bhattacharya, P.Wang, L.Wang, S.Basu, J.A.Nagy, A.Atala, D.Mukhopadhyay, and S.Soker. 2005. Antiangiogenic properties of gold nanoparticles. Clinical Cancer Research 11:3530–34. doi:10.1158/1078-0432.CCR-04-2482.
80. S.K.Nethi,, S.Mukherjee, V.Veeriah, A.K.Barui, S.Chatterjee, and C.R.Patra. 2014. Bioconjugated gold nanoparticles accelerate the growth of new blood vessels through redox signaling. Chemical Communications 50:14367–70. doi:10.1039/C4CC06996J.
81. G.Oberdörster,, V.Castranova, B.Asgharian, and P.Sayre. 2015. Inhalation exposure to carbon nanotubes (CNT) and carbon nanofibers (CNF): Methodology and dosimetry. Journal of Toxicology and Environmental Health, Part B 18:121–212. doi:10.1080/10937404.2015.1051611.
82. G.Oberdörster,, E.Oberdörster, and J.Oberdörster. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environmental Health Perspectives 113:823–39. doi:10.1289/ehp.7339.
83. Organization for Economic Cooperation and Development. 2012. Guidance on sample preparation and dosimetry for the safety. Series on the Safety of Manufactured Nanomaterials. Paris, France: OECD Publications Service.
84. E.M.Paleolog, 2009. The vasculature in rheumatoid arthritis: Cause or consequence? International Journal of Experimental Pathology 90:249–61. doi:10.1111/j.1365-2613.2009.00640.x.
85. Y.Pan,, Q.Wu, R.Liu, M.Shao, J.Pi, X.Zhao, and L.Qin. 2014a. Inhibition effects of gold nanoparticles on proliferation and migration in hepatic carcinoma-conditioned HUVECs. Bioorganic & Medicinal Chemistry Letters 24:679–84. doi:10.1016/j.bmcl.2013.11.045.
86. Y.Pan,, Q.Wu, L.Qin, J.Cai, and B.Du. 2014b. Gold nanoparticles inhibit VEGF165-induced migration and tube formation of endothelial cells via the Akt pathway. BioMedical Research International 2014:418624.
87. C.Parnsamut,, and S.Brimson. 2015. Effects of silver nanoparticles and gold nanoparticles on IL-2, IL-6, and TNF-α production via MAPK pathway in leukemic cell lines. Genetics and Molecular Research 14:3650–68. doi:10.4238/2015.April.17.15.
88. M.M.Paula,, F.Petronilho, F.Vuolo, G.K.Ferreira, L.De Costa, G.P.Santos, P.S.Effting, F.Dal-Pizzol, A.G.Dal-Bo, T.E.Frizon, P.C.Silveira, and R.A.Pinho. 2015. Gold nanoparticles and/or N-acetylcysteine mediate carrageenan-induced inflammation and oxidative stress in a concentration-dependent manner. Journal of Biomedical Materials Research, Part A 103:3323–30. doi:10.1002/jbm.a.35469.
89. S.Ramiro,, C.Gaujoux-Viala, J.L.Nam, J.S.Smolen, M.Buch, L.Gossec, D.Van Der Heijde, K.Winthrop, and R.Landewé. 2014. Safety of synthetic and biological DMARDs: A systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Annals of the Rheumatic Diseases 73:529–35. doi:10.1136/annrheumdis-2013-204575.
90. N.S.Rawson,, S.R.Harding, E.Malcolm, and L.Lueck. 1998. Hospitalizations for aplastic anemia and agranulocytosis in Saskatchewan: Incidence and associations with antecedent prescription drug use. Journal of Clinical Epidemiology 51:1343–55. doi:10.1016/S0895-4356(98)00072-9.
91. R.G.Rayavarapu,, W.Petersen, L.Hartsuiker, P.Chin, H.Janssen, F.W.Van Leeuwen, C.Otto, S.Manohar, and T.G.Van Leeuwen. 2010. In vitro toxicity studies of polymer-coated gold nanorods. Nanotechnology 21:145101. doi:10.1088/0957-4484/21/14/145101.
92. A.San Martin,, and K.K.Griendling. 2010. Redox control of vascular smooth muscle migration. Antioxidants & Redox Signaling 12:625–40. doi:10.1089/ars.2009.2852.
93. A.Sanchez,, A.C.Calpena, and B.Clares. 2015. Evaluating the oxidative stress in inflammation: Role of melatonin. International Journal of Molecular Sciences 16:16981–7004. doi:10.3390/ijms160816981.
94. M.E.Selim,, Y.M.Abd-Elhakim, and L.Y.Al-Ayadhi. 2015. Pancreatic response to gold nanoparticles includes decrease of oxidative stress and inflammation in autistic diabetic model. Cellular Physiology and Biochemistry 35:586–600. doi:10.1159/000369721.
95. M.C.Senut,, Y.Zhang, F.Liu, A.Sen, D.M.Ruden, and G.Mao. 2016. Size-dependent toxicity of gold nanoparticles on human embryonic stem cells and their neural derivatives. Small 12:631–46. doi:10.1002/smll.201502346.
96. R.Shrivastava,, P.Kushwaha, Y.C.Bhutia, and S.Flora. 2014. Oxidative stress induced following exposure to silver and gold nanoparticles in mice. Toxicology and Industrial Health doi:10.1177/0748233714562623.
97. P.C.Silveira,, E.G.Victor, F.S.Notoya, D.D.Scheffer, L.D.Silva, R.B.Cantu, V.H.Martinez, R.A.De Pinho, and M.M.Paula. 2015. Effects of phonophoresis with gold nanoparticles on oxidative stress parameters in a traumatic muscle injury model. Drug Delivery 23:1–7.
98. J.Smolen,, M.Boers, E.C.Abadie, F.C.Breedveld, P.Emery, T.Bardin, N.Goel, D.J.Ethgen, B.P.Avouac, W.H.Dere, P.Durez, M.Matucci-Cerinic, B.Flamion, A.Laslop, F.J.Lekkerkerker, P.Miossec, B.H.Mitlak, S.Ormarsdóttir, L.Paolozzi, R.Rao, S.Reiter, Y.Tsouderos, J.Y.Reginster, and Group for Respect of Ethics and Excellence in Science (GREES). 2011. Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RA. Current Medical Research and Opinion 27:315–25. doi:10.1185/03007995.2010.542135.
99. G.Sonavane,, K.Tomoda, and K.Makino. 2008. Biodistribution of colloidal gold nanoparticles after intravenous administration: Effect of particle size. Colloids and Surfaces B: Biointerfaces 66:274–80. doi:10.1016/j.colsurfb.2008.07.004.
100. K.J.Stone,, S.J.Mather, and P.P.Gibson. 1975. Selective inhibition of prostaglandin biosynthesis by gold salts and phenylbutazone. Prostaglandins 10:241–51. doi:10.1016/S0090-6980(75)80077-3.
101. R.C.Stone,, B.D.Fellows, B.Qi, D.Trebatoski, B.Jenkins, Y.Raval, T.R.Tzeng, T.F.Bruce, T.McNealy, M.J.Austin, T.C.Monson, D.L.Huber, and O.T.Mefford. 2015. Highly stable multi-anchored magnetic nanoparticles for optical imaging within biofilms. Journal of Colloid and Interface Science 459:175–82. doi:10.1016/j.jcis.2015.08.012.
102. M.Subramaneyaan,, S.Yasmeen, R.S.Ahmed, V.K.Arora, A.K.Tripathi, and B.D.Banerjee. 2013. Evaluation of therapeutic efficacy of Majoon Suranjan, a Unani formulation, in the treatment of rheumatoid arthritis: An experimental study. Experimental Biology and Medicine 238:1379–87. doi:10.1177/1535370213498983.
103. V.Sumbayev,, I.M.Yasinska, C.P.Garcia, D.Gilliland, G.S.Lall, B.F.Gibbs, D.R.Bonsall, L.Varani, F.Rossi, and L.Calzolai. 2013. Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses. Small 9:472–77. doi:10.1002/smll.201201528.
104. M.Tarantola,, A.Pietuch, D.Schneider, J.Rother, E.Sunnick, C.Rosman, S.Pierrat, C.Sonnichsen, J.Wegener, and A.Janshoff. 2011. Toxicity of gold-nanoparticles: Synergistic effects of shape and surface functionalization on micromotility of epithelial cells. Nanotoxicology 5:254–68. doi:10.3109/17435390.2010.528847.
105. U.Taylor,, C.Rehbock, C.Streich, D.Rath, and S.Barcikowski. 2014. Rational design of gold nanoparticle toxicology assays: A question of exposure scenario, dose and experimental setup. Nanomedicine 9:1971–89. doi:10.2217/nnm.14.139.
106. A.S.Thakor,, J.Jokerst, C.Zavaleta, T.F.Massoud, and S.S.Gambhir. 2011. Gold nanoparticles: A revival in precious metal administration to patients. Nano Letters 11:4029–936. doi:10.1021/nl202559p.
107. D.Tiedemann,, U.Taylor, C.Rehbock, J.Jakobi, S.Klein, W.A.Kues, S.Barcikowski, and D.Rath. 2014. Reprotoxicity of gold, silver, and gold-silver alloy nanoparticles on mammalian gametes. Analyst 139:931–42. doi:10.1039/C3AN01463K.
108. M.A.Toscano,, G.A.Bianco, J.M.Ilarregui, D.O.Croci, J.Correale, J.D.Hernandez, N.W.Zwirner, F.Poirier, E.M.Riley, L.G.Baum, and G.A.Rabinovich. 2007. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nature Immunology 8:825–34. doi:10.1038/ni1482.
109. J.Tournebize,, A.Boudier, O.Joubert, H.Eidi, G.Bartosz, P.Maincent, P.Leroy, and A.Sapin-Minet. 2012. Impact of gold nanoparticle coating on redox homeostasis. International Journal of Pharmaceutics 438:107–16. doi:10.1016/j.ijpharm.2012.07.026.
110. E.C.Tozman,, and N.L.Gottlieb. 1987. Adverse reactions with oral and parenteral gold preparations. Medical Toxicology 2:177–89. doi:10.1007/BF03259863.
111. L.Truong,, K.S.Saili, J.M.Miller, J.E.Hutchison, and R.L.Tanguay. 2012. Persistent adult zebrafish behavioral deficits results from acute embryonic exposure to gold nanoparticles. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology 155:269–74. doi:10.1016/j.cbpc.2011.09.006.
112. C.Y.Tsai,, A.L.Shiau, S.Y.Chen, Y.H.Chen, P.C.Cheng, M.Y.Chang, D.H.Chen, C.H.Chou, C.R.Wang, and C.L.Wu. 2007. Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis and Rheumatism 56:544–54. doi:10.1002/art.22401.
113. M.Turner,, V.B.Golovko, O.P.H.Vaughan, O.P.Vaughan, P.Abdulkin, A.Berenguer-Murcia, M.S.Tikhov, B.F.Johnson, and R.M.Lambert. 2008. Selective oxidation with dioxygen by gold nanoparticle catalysts derived from 55-atom clusters. Nature 454:U31–981. doi:10.1038/nature07194.
114. G.Von Maltzahn,, J.H.Park, A.Agrawal, N.K.Bandaru, S.K.Das, M.J.Sailor, and S.N.Bhatia. 2009. Computationally guided photothermal tumor therapy using long circulating gold nanorod antennas. Cancer Research 69:3892–900. doi:10.1158/0008-5472.CAN-08-4242.
115. W.J.Westwick,, J.Allsop, and R.W.Watts. 1974. The effect of gold salts on the biosynthesis of uridine nucleotides in human granulocytes. Biochemical Pharmacology 23:153–62. doi:10.1016/0006-2952(74)90321-9.
116. H.P.Wright, 1948. Present status of gold therapy in rheumatoid arthritis. Canadian Medical Association Journal 59:359–63.
117. M.Yao,, L.He, D.J.McClements, and H.Xiao. 2015. Uptake of gold nanoparticles by intestinal epithelial cells: Impact of particle size on their absorption, accumulation, and toxicity. Journal of Agricultural and Food Chemistry 63:8044–49. doi:10.1021/acs.jafc.5b03242.
118. K.-N.Yu,, J.E.Kim, H.W.Seo, C.Chae, and M.-H.Cho. 2013. Differential toxic responses between pristine and functionalized multiwall nanotubes involve induction of autophagy accumulation in murine lung. Journal of Toxicology and Environmental Health, Part A 76:1282–92. doi:10.1080/15287394.2013.850137.
119. H.Zhang,, Z.Ji, T.Xia, H.Meng, C.Low-Kam, R.Liu, S.Pokhrel, S.Lin, X.Wang, Y.P.Liao, M.Wang, L.Li, R.Rallo, R.Damoiseaux, D.Telesca, L.Madler, Y.Cohen, J.I.Zink, and A.E.Nel. 2012. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 6:4349–68. doi:10.1021/nn3010087.
120. Q.Zhang,, N.Iwakuma, P.Sharma, B.M.Moudgil, C.Wu, J.McNeill, H.Jiang, and S.R.Grobmyer. 2009. Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustic tomography. Nanotechnology 20:395102. doi:10.1088/0957-4484/20/39/395102.
121. X.D.Zhang,, H.Y.Wu, D.Wu, Y.Y.Wang, J.H.Chang, Z.B.Zhai, A.M.Meng, P.X.Liu, L.A.Zhang, and F.Y.Fan. 2010. Toxicologic effects of gold nanoparticles in vivo by different administration routes. International Journal of Nanomedicine 5:771–81.
122. J.Zhao,, and V.Castranova. 2011. Toxicology of nanomaterials used in nanomedicine. Journal of Toxicology and Environmental Health, Part B 14:593–632. doi:10.1080/10937404.2011.615113.
123. Y.Zhao,, B.Pang, H.Luehmann, L.Detering, X.Yang, D.Sultan, S.Harpstrite, V.Sharma, C.S.Cutler, Y.Xia, and Y.Liu. 2016. Gold nanoparticles doped with 199 Au atoms and their use for targeted cancer imaging by SPECT. Advancement Health Materials. 5: 928–35.